Home » News » Astra vaccination over 65 years old, re-discussed next month after seeing additional clinical results in the US

Astra vaccination over 65 years old, re-discussed next month after seeing additional clinical results in the US

[코로나19 백신]

It is unknown whether the efficacy of the US clinical trial will be proven after April and until next month.
1st quarter vaccinations decreased from 1.3 million to 760,000… The burden of vaccination increased after the second quarter
Expert “There is no alternative vaccine, but high-risk group vaccination is postponed, post-storm fear”

On the 15th, a new coronavirus infection (Corona 19) vaccine vaccination center was installed at the Mokpo Indoor Gymnasium in Mokpo-si, Jeollanam-do. The government announced that it will start vaccinating COVID-19 for residents and workers in nursing hospitals and facilities under the age of 65 from the 26th. Mokpo = Reporter Park Young-cheol [email protected]-The reason why the government excluded 65 years of age or older from the targets of the new coronavirus infection (Corona 19) vaccination of AstraZeneca in the UK was because it judged that the vaccine effect was not sufficiently verified at that age group. Accordingly, there are concerns that the entire vaccination schedule will be changed as the vaccination of patients 65 years of age or older and residents of the facility, which was the top priority, has been delayed for about two months since the end of March.

○ Even at the end of March, vaccination for the elderly’Well’

On this day, the Korea Centers for Disease Control and Prevention (DMI) announced that it had decided to withhold AstraZeneca vaccination for those over 65 years old at the judgment of the affiliated vaccination committee. The number of elderly people whose vaccinations have been postponed by this decision reached 376,724.

The committee recognized the safety and death-preventing effects of the AstraZeneca vaccine. However, he said, “there is a lack of statistical evidence on the efficacy of the vaccine in the age group over 65,” he said. “If there is a controversy about the efficacy of the vaccine against the elderly, it may lower the vaccination rate.

The Agency for Disease Control and Prevention decided to re-determine whether to inoculate the AstraZeneca vaccine to the elderly by securing additional data, including data from US clinical trials, by the end of March. Among the subjects of the phase 3 clinical trial in the United States, about 22% of the elderly aged 65 or older are known to be of sufficient size to demonstrate the effect of the elderly. However, the final clinical trial is expected to be completed only in April. In a briefing on the day, Chung Eun-kyung said, “There will be (clinical) interim results or data on evaluating vaccine effectiveness after vaccination in countries where vaccination has already begun, such as the UK.” However, as this is not the final clinical result, controversy may continue.

○ Concerns about disruption to the entire vaccination schedule

-The first vaccinations for those under the age of 65 will start on the 26th of this month. The government plans to complete the selection of the list of 272,131 people eligible for vaccination in nursing hospitals and facilities by the 19th. The vaccination of 3,54,309 workers in high-risk medical institutions such as senior hospitals with a large number of critically ill patients will begin on March 8, and the vaccination of 78513 first responders to Corona 19, including 119 paramedics, will begin in March. They are inoculated with AstraZeneca. In addition, 54729 workers at Corona 19 medical institutions plan to start vaccination as soon as the Pfizer vaccine is received from COVAX Facility (International Vaccine Sharing Project). A total of 75,9412 people were eligible for vaccination in the first quarter reflecting this. This is less than the 1.3 million targets for the first quarter (January to March) vaccinations announced by the government last month. As the number of vaccinations in the first quarter has decreased, the vaccination burden will inevitably increase after the second quarter (April to June). Initially, the government planned to inoculate 9 million people in the second quarter and more than 30 million people in the third to fourth quarters to complete the collective immunity of 70% of the population by November. “In the case of influenza (flu) vaccines, even in the case of influenza (flu) vaccines, nearly 15 million people will be vaccinated for two months in October and November,” said Chung. “It is very difficult, but consigned medical institutions, vaccination centers, etc. “We will systematically prepare for vaccination by mobilizing various organizations.”

○ Experts “Postponed vaccination without alternative”

Among experts, it is pointed out that delaying vaccination for the elderly with a high fatality rate can be a’handshake’ of the quarantine authorities. Joong-sik Eom, professor of infectious medicine at Gachon University Gil Hospital, said, “It is to delay vaccination for the elderly by 4 to 8 weeks without introducing an alternative vaccine. For that reason, the WHO also recommended that AstraZeneca be given if there is no other alternative.” Choi Won-seok, a professor of infectious medicine at Korea University Ansan Hospital, pointed out that “protecting the high-risk group and maintaining the medical system is the most important goal of vaccination,” and “we had to take a good look at which choice was more beneficial to the high-risk group.”

Meanwhile, there is controversy over the government’s decision to cover 70% of the cost of vaccination through health insurance. That is why it is not actually a’free vaccination’. The Ministry of Health and Welfare explained that “the insurance money can be used for the health and safety of health insurance subscribers.”

Image [email protected]Go to reporter page>Reporter Kim So-min

Close window

You recommended the articleAstra vaccination over 65 years old, re-discussed next month after seeing additional clinical results in the USBest Recommended News

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.